These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 11877365)
81. [Pharmacological analysis of the role of central alpha-2 adrenergic and imidazoline receptors in mechanism of the hypotensive effect of clonidine in rats]. Kuz'min AI; Lodygin DN; Kalenikova EI; Bychkova EIu; Khokhlova ON; Murashev AN; Medvedev OS Eksp Klin Farmakol; 2000; 63(4):24-8. PubMed ID: 11022301 [TBL] [Abstract][Full Text] [Related]
82. Actions of L-NAME and methylene blue on the hypotensive effects of clonidine and rilmenidine in the anesthetized rat. Soares de Moura RS; Leão MC; Castro Resende AC; Moreira CF; Sena KM; Silveira SS; Lima AF; Nunes FR; Mesquita Ferreira AG J Cardiovasc Pharmacol; 2000 May; 35(5):791-5. PubMed ID: 10813383 [TBL] [Abstract][Full Text] [Related]
83. Comparative study of NMDA and AMPA/kainate receptors involved in cardiovascular inhibition produced by imidazoline-like drugs in anaesthetized rats. Wang LG; Zeng J; Yuan WJ; Su DF; Wang WZ Exp Physiol; 2007 Sep; 92(5):849-58. PubMed ID: 17573415 [TBL] [Abstract][Full Text] [Related]
84. [[Central agents in arterial hypertension: back to the future]. Robles NR Nefrologia; 2000; 20(4):302-10. PubMed ID: 11039256 [No Abstract] [Full Text] [Related]
85. Chronic ethanol attenuates centrally-mediated hypotension elicited via alpha(2)-adrenergic, but not I(1)-imidazoline, receptor activation in female rats. El-Mas MM; Abdel-Rahman AA Life Sci; 2009 Jan; 84(3-4):111-8. PubMed ID: 19041658 [TBL] [Abstract][Full Text] [Related]
86. Heterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists. Tan CM; Wilson MH; MacMillan LB; Kobilka BK; Limbird LE Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12471-6. PubMed ID: 12205290 [TBL] [Abstract][Full Text] [Related]
88. Rilmenidine: a novel antihypertensive agent. Safar ME Am J Med; 1989 Sep; 87(3C):24S-29S. PubMed ID: 2571292 [TBL] [Abstract][Full Text] [Related]
89. Pretreatment with the dopamine agonist quinpirole inhibits central antihypertensive mechanisms in rats. van den Buuse M; Tritton SB Clin Exp Pharmacol Physiol; 1997; 24(9-10):661-6. PubMed ID: 9315366 [TBL] [Abstract][Full Text] [Related]
91. Rilmenidine (S 3341) and the sympathoadrenal system: adrenoreceptors, plasma and adrenal catecholamines in dogs. Valet P; Tran MA; Damase-Michel C; de Saint-Blanquat G; Dang Tran L; Anglade F; Koenig-Berard E; Montastruc JL J Auton Pharmacol; 1988 Dec; 8(4):319-26. PubMed ID: 2908112 [TBL] [Abstract][Full Text] [Related]
92. Modulation of sympathetic outflow by centrally acting antihypertensive drugs. van Zwieten PA Cardiovasc Drugs Ther; 1996 Jun; 10 Suppl 1():283-9. PubMed ID: 8827951 [TBL] [Abstract][Full Text] [Related]
93. Preliminary clinical pharmacological studies of S3341, a new hypotensive agent, and comparison with clonidine in normal males. Weerasuriya K; Shaw E; Turner P Eur J Clin Pharmacol; 1984; 27(3):281-6. PubMed ID: 6150856 [TBL] [Abstract][Full Text] [Related]
94. Mechanism of hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155) in the cat. Magus RD; Long JP J Pharm Sci; 1968 Apr; 57(4):594-8. PubMed ID: 5652149 [No Abstract] [Full Text] [Related]
95. Alpha 2-adrenergic mechanisms of analgesia: strategies for improving their therapeutic window and identification of the novel, potent alpha 2A-adrenergic receptor agonist, S 18616. Millan MJ Adv Pharmacol; 1998; 42():575-9. PubMed ID: 9327967 [No Abstract] [Full Text] [Related]